Yoshikuni Inokawa

Gifu Prefectural Tajimi Hospital — Japan

Medicine · Health Sciences

22h-index1.6kcitations127works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(27), RNA modifications and cancer(16), Gastric Cancer Management and Outcomes(15), Cancer-related gene regulation(15), Hepatocellular Carcinoma Treatment and Prognosis(13)

Publications127 total

Close correlation between patients' positive mood and postoperative complication burden in hepato-biliary-pancreatic cancer: a prospective comparative cohort trial
HPB·2025Open Access
Durvalumab-combined chemotherapy for biliary tract cancer in a Japanese expert center: initial 50 cases in daily practice.
PubMed·2025Open Access
Exploration of Lipid Mediators for Therapeutic Monitoring of Pancreatic Cancer Patients
Anticancer Research·2025Open Access
Pathological Complete Response after Pembrolizumab Treatment for Unresectable Perihilar Cholangiocarcinoma with High Microsatellite Instability: A Case Report
Surgical Case Reports·2025· 1 citedOpen Access
A Case of Appendiceal Endometriosis that Presented as an Appendiceal Mucocele Treated by Partial Excision of the Cecum
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)·2025Open Access
Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after <scp>FOLFIRINOX</scp> or gemcitabine plus nab‐paclitaxel chemotherapy: A multicenter retrospective cohort study (<scp>PC</scp>‐<scp>CURE</scp>‐1)
Journal of Hepato-Biliary-Pancreatic Sciences·2024· 7 citedOpen Access
The impact of goal-directed prehabilitation therapy on functional capacity in patients undergoing hepatobiliary and pancreatic surgery: A randomized clinical trial
Surgery·2024· 5 cited
ASO Visual Abstract: Absence of Hypercoagulation Status After Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma
Annals of Surgical Oncology·2024
Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways
Gastric Cancer·2024· 10 citedOpen Access
Absence of Hypercoagulation Status after Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma
Annals of Surgical Oncology·2024· 6 cited
A Case of Desmoid Tumor Resected by Laparoscopic Distal Pancreatectomy
The Japanese Journal of Gastroenterological Surgery·2024Open Access
Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth <i>via</i><scp>BCL</scp>‐2‐mediated intrinsic apoptosis
International Journal of Cancer·2023· 4 citedOpen Access
Increased <scp>STX3</scp> transcript and protein levels were associated with poor prognosis in two independent cohorts of esophageal squamous cell carcinoma patients
Cancer Medicine·2023· 2 citedOpen Access
Predictive impacts of peritoneal washing cytology for surgical resection‐intended pancreatic cancer cases: Establishment of planned staging laparoscopy criteria
Journal of Hepato-Biliary-Pancreatic Sciences·2023· 5 cited
Identification of stromal cell-derived factor 4 as a liquid biopsy-based diagnostic marker in solid cancers
Scientific Reports·2023· 5 citedOpen Access
39. HIGH PREOPERATIVE PLATELET TO LYMPHOCYTE RATIO IS ASSOCIATED WITH A GREATER RISK OF POSTOPERATIVE COMPLICATIONS AND RECURRENCES IN ESOPHAGEAL CANCER
Diseases of the Esophagus·2023Open Access
27. OPLAH PROTEIN EXPRESSION STRATIFIES THE PROGNOSIS OF PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS
Diseases of the Esophagus·2023Open Access
Supplementary Data from Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard Chemotherapy
2023Open Access
Data from Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard Chemotherapy
2023Open Access
Data from Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard Chemotherapy
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Yasuhiro Kodera(44), Suguru Yamada(33), Shuji Nomoto(31), Tsutomu Fujii(27), Hiroyuki Sugimoto(26), Masamichi Hayashi(26), Mitsuro Kanda(26), Chie Tanaka(23), Goro Nakayama(23), Masahiko Koike(22), Hideki Takami(20), Fuminori Sonohara(16), Mitsuro Kanda(14), Michitaka Fujiwara(14), Dai Shimizu(13), Yoko Nishikawa(12), Masaya Suenaga(11), Mitsuhiro Hishida(11), Norifumi Hattori(10), Daisuke Kobayashi(9)